Linaclotide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Linaclotide
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Linaclotide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 14 USDMF, 1 JDMF, 2 EU WC, 6 NDC API, 24 Listed Suppliers, $ API Reference Price

37 API Suppliers
14 USDMF
1 JDMF
2 EU WC
6 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

39 Drugs in Development

39 Drugs in Development

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 8 FDA Orange Book, 9 Europe, 3 Canada, 5 Listed Dossiers

25 FDF Dossiers
8 FDA Orange Book
9 Europe
3 Canada
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 145MCG, CAPSULE;ORAL - 290MCG, CAPSULE;ORAL - 72MCG

CAPSULE;ORAL - 145MCG
CAPSULE;ORAL - 290MCG
CAPSULE;ORAL - 72MCG

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 SPI Pharma, 8 DKSH, 2 Gangwal Healthcare, 1 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures, 12 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 9 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 Silverline Chemicals, 2 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 23 Fillers, Diluents & Binders, 18 Controlled & Modified Release, 14 Thickeners and Stabilizers, 9 Empty Capsules, 9 Direct Compression, 7 Granulation, 7 Co-Processed Excipients, 6 Parenteral, 6 Film Formers & Plasticizers, 6 Disintegrants & Superdisintegrants, 5 Taste Masking, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 4 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 4 Lubricants & Glidants, 1 Solubilizers, 1 Emulsifying Agents, 1 Topical

44 Coating Systems & Additives
23 Fillers, Diluents & Binders
18 Controlled & Modified Release
14 Thickeners and Stabilizers
9 Empty Capsules
9 Direct Compression
7 Granulation
7 Co-Processed Excipients
6 Parenteral
6 Film Formers & Plasticizers
6 Disintegrants & Superdisintegrants
5 Taste Masking
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
4 Rheology Modifiers
4 Chewable & Orodispersible Aids
4 Lubricants & Glidants
1 Solubilizers
1 Emulsifying Agents
1 Topical

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 47 News #PharmaBuzz

1 Data Compilation #PharmaFlow
47 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 8 Regulatory FDF Prices, 16 Annual Reports

1 US Medicaid Prescriptions
8 Regulatory FDF Prices
16 Annual Reports

MARKET PLACE

14 APIs

14 APIs

PATENTS & EXCLUSIVITIES

24 US Patents, 2 US Exclusivities, 7 Health Canada Patents

24 US Patents
2 US Exclusivities
7 Health Canada Patents

$ API Ref.Price (USD/KG) : 874,103 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7AbbVie Corporation

filter Patent Reset all filters

7 All

01 32514507

02 32732892

03 12808091

filter Product Reset all filters

7 All

01 7LINACLOTIDE

filter Dosage Reset all filters

7 All

01 7CAPSULE

filter Exp Date Reset all filters

7 All

01 32024-01-28

02 32029-08-14

03 12031-08-11

Product Main Page

01

AbbVie Corporation

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 145 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AbbVie Corporation

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 290 ug

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AbbVie Corporation

LINACLOTIDE

Luxepack

Not Confirmed

AbbVie Corporation

Country

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2732892

Filing Date : 2009-08-14

Strength per Unit : 290 ug

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

AbbVie Corporation

LINACLOTIDE

Luxepack

Not Confirmed

AbbVie Corporation

Country

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2514507

Filing Date : 2004-01-28

Strength per Unit : 72 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-01-28

Date Granted : 2012-03-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

AbbVie Corporation

LINACLOTIDE

Luxepack

Not Confirmed

AbbVie Corporation

Country

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-11

Date Granted : 2019-05-21

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2808091

Filing Date : 2011-08-11

Strength per Unit : 72 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-08-11

Date Granted : 2019-05-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

AbbVie Corporation

LINACLOTIDE

Luxepack

Not Confirmed

AbbVie Corporation

Country

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2732892

Filing Date : 2009-08-14

Strength per Unit : 145 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

AbbVie Corporation

LINACLOTIDE

Luxepack

Not Confirmed

AbbVie Corporation

Country

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

LINACLOTIDE

Brand Name : CONSTELLA

Patent Number : 2732892

Filing Date : 2009-08-14

Strength per Unit : 72 ?g

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-14

Date Granted : 2020-12-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!